Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients
Rosa Ayala(Hospital Universitario 12 De Octubre), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Carlos Jiménez(University of Cartagena), Rosalía Bustelos(Hospital Universitario del Sureste), Carmen Ribera(Research Institute Hospital 12 de Octubre), Álvaro García‐Sesma(Research Institute Hospital 12 de Octubre), Enrique Moreno(Research Institute Hospital 12 de Octubre), Silvia Grande(Research Institute Hospital 12 de Octubre)
Cited by 62
Related Papers
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523